Jacques-François Martin
Directeur Général chez Rhein Biotech GmbH
Profil
Jacques-François Martin is currently the Chairman & CEO of Parteurop, Chairman-Supervisory Board of Rhein Biotech GmbH, and Co-President & Director of Tollys.
He previously held positions such as Chairman, President & CEO of Mymetics Corp., CEO of Sanofi Pasteur, Inc., and CEO of Pasteur Merieux MSD Ltd.
He was also the Chairman of Anergis SA and Fabentech SAS.
Additionally, he served as a Director-Emeritus of the International AIDS Vaccine Initiative, Inc. and a Director of Vétoquinol SA. He holds an MBA from École des Hautes Études Commerciales de Paris.
Postes actifs de Jacques-François Martin
| Sociétés | Poste | Début |
|---|---|---|
Rhein Biotech GmbH
 Rhein Biotech GmbH Medical SpecialtiesHealth Technology Rhein Biotech GmbH develops, manufactures and markets biopharmaceutical products and technologies. Its products treat and prevent infectious diseases, allergies, cancer, and chronic inflammatory diseases. The company was founded by Cornelis P. Hollenberg and Zbigniew Janowicz in 1985 and is located in Dusseldorf, Germany. | Directeur Général | - |
Parteurop
 Parteurop Financial ConglomeratesFinance Parteurop is a private equity firm that focuses on investments in the life sciences industry. The private company is based in Lyon, France. and has subsidiaries in France. The CEO of the French company is Jacques-François Martin. | Directeur Général | 12/05/2010 |
Tollys
 Tollys Hospital/Nursing ManagementHealth Services Tollys is a French company that specializes in developing clinical-grade TLR3 ligands for cancer immunotherapy. The company is based in Lyon, France and was founded by Dominique Rigal. The company's co-founders discovered that TLR3 agonists have the potential to induce direct and immunogenic tumor cell death while sparing normal cells. Tollys has filled a patent for a new family of TLR3 ligands and confirmed freedom to operate. The CEO is Vincent Charlon. | President | - |
Anciens postes connus de Jacques-François Martin
| Sociétés | Poste | Fin |
|---|---|---|
| MYMETICS CORPORATION | Directeur Général | 23/03/2012 |
International AIDS Vaccine Initiative, Inc.
 International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Corporate Officer/Principal | 01/06/2003 |
Institut National de la Santé & de la Recherche Médicale
 Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Directeur/Membre du Conseil | 01/01/1999 |
Sanofi Pasteur, Inc.
 Sanofi Pasteur, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Pasteur, Inc. provides vaccines for the prevention and treatment of diseases. It develops and manufactures influenza vaccine against the pandemic influenza virus. The company was founded in 1897 and is headquartered in Swiftwater, PA. | Directeur Général | 01/01/1991 |
Fabentech SAS
 Fabentech SAS Medical/Nursing ServicesHealth Services Fabentech SAS developes immunotherapeutic solutions for emerging infectious diseases as well as for certain drug intoxications. Its products include infography development, Lassa(FBH-003) and other emerging diseases. The company was founded by Bertrand Lepine on June 5, 2009 and is headquartered in Lyon, France. | Président | - |
Formation de Jacques-François Martin
| École des Hautes Études Commerciales de Paris | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MYMETICS CORPORATION | Health Technology |
| VETOQUINOL SA | Health Technology |
| Entreprise privées | 14 |
|---|---|
Biotek Partenaires SAS
 Biotek Partenaires SAS Investment ManagersFinance Biotek Partenaires SAS (Biotek Partenaires) is a venture capital firm, a subsidiary of Banque Saint Olive. The firm is founded in 1998 by Saint-Olive. The firm headquartered in Lyon, France. | Finance |
Rhein Biotech GmbH
Rhein Biotech GmbH Medical SpecialtiesHealth Technology Rhein Biotech GmbH develops, manufactures and markets biopharmaceutical products and technologies. Its products treat and prevent infectious diseases, allergies, cancer, and chronic inflammatory diseases. The company was founded by Cornelis P. Hollenberg and Zbigniew Janowicz in 1985 and is located in Dusseldorf, Germany. | Health Technology |
Parteurop
Parteurop Financial ConglomeratesFinance Parteurop is a private equity firm that focuses on investments in the life sciences industry. The private company is based in Lyon, France. and has subsidiaries in France. The CEO of the French company is Jacques-François Martin. | Finance |
Sanofi Pasteur, Inc.
Sanofi Pasteur, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Pasteur, Inc. provides vaccines for the prevention and treatment of diseases. It develops and manufactures influenza vaccine against the pandemic influenza virus. The company was founded in 1897 and is headquartered in Swiftwater, PA. | Health Technology |
| Rhone-Poulenc Pharma GmbH | |
Institut Mérieux SA
 Institut Mérieux SA BiotechnologyHealth Technology Institut Mérieux SA provides solutions for multifactorial management of diseases. The firm provides solutions for diseases, including tuberculosis, liver cancer and hepatitis. It specializes in the field human and veterinary of vaccines. It operates under the activities of diagnostics, immunotherapy and nutrition. The company was founded by Marcel Mérieux in 1897 and is headquartered Lyon, France. | Health Technology |
Institut National de la Santé & de la Recherche Médicale
Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Commercial Services |
| GAVI Alliance | Miscellaneous |
Académie des Technologies
 Académie des Technologies Academie des Technologies engages in the technology industry. The company was founded in December 2000 and is headquartered in Paris, France. | |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Health Technology |
| Pasteur Merieux MSD Ltd. | |
Anergis SA
 Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland. | Health Technology |
Fabentech SAS
Fabentech SAS Medical/Nursing ServicesHealth Services Fabentech SAS developes immunotherapeutic solutions for emerging infectious diseases as well as for certain drug intoxications. Its products include infography development, Lassa(FBH-003) and other emerging diseases. The company was founded by Bertrand Lepine on June 5, 2009 and is headquartered in Lyon, France. | Health Services |
Tollys
Tollys Hospital/Nursing ManagementHealth Services Tollys is a French company that specializes in developing clinical-grade TLR3 ligands for cancer immunotherapy. The company is based in Lyon, France and was founded by Dominique Rigal. The company's co-founders discovered that TLR3 agonists have the potential to induce direct and immunogenic tumor cell death while sparing normal cells. Tollys has filled a patent for a new family of TLR3 ligands and confirmed freedom to operate. The CEO is Vincent Charlon. | Health Services |
